CollPlant Biotechnologies (CLGN) EBT Margin Growth (5y) (2022 - 2025)

CollPlant Biotechnologies (CLGN) EBT Margin Growth (5y) (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn -
7 Psyence Biomedical 251.43 Bn 251.42 Bn -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn
9 Abivax 94.37 Bn 94.37 Bn -
10 CollPlant Biotechnologies 7.20 Mn 7.20 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -502,770.00
Sep 30, 2025 -67.96 Mn
Jun 30, 2025 200,446.00
Mar 31, 2025 35,704.00
Dec 31, 2024 -77,215.00
Sep 30, 2024 -11.35 Mn
Jun 30, 2024 137,393.00
Mar 31, 2024 406,499.00
Dec 31, 2023 -162,957.00
Sep 30, 2023 -63,305.00
Jun 30, 2023 -54,590.00
Mar 31, 2023 -1,219.00
Dec 31, 2022 -871,116.00